Session 9: Rapporteur Summary on Policy Implications

download Session 9: Rapporteur Summary on Policy Implications

of 9

Transcript of Session 9: Rapporteur Summary on Policy Implications

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    1/9

    Policy

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    2/9

    Reducing Risk of Biosafety Failures

    -a systems approach involving investigators and research staff,

    institutional support and leadership, and reviews by funders are

    needed for both the initial proposal and for each change in

    protocol.

    - reviews should include representation from the wider

    community of affected parties, e.g. local law enforcement, fire

    departments, medical facilities, public health officials etc.

    -stakeholders may well need contingency plans in case of a

    community outbreak, as well as special procedures for

    management of crises

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    3/9

    -In light of the resources needed to do the GoF one might argue that the

    money would be better spent if re-directed to more conventional endeavors

    but this assumes a fixed budget and zero-sum trade-offs among research

    investments and public health investments; recent history of appropriations

    process does not necessarily bear this out.

    - can also be argued that the risks of GoF research are imposed on the general

    public whereas its benefits are unevenly distributed, and weighted toward

    those who are better off or countries that are more developed, as an

    incidental effect of their economic and health care systems.

    -The implication is either that GoF work should not be done, or that if it is

    done, then the fruits of the research must be made more broadly available

    across all peoples.

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    4/9

    Question

    Is the issue the value of GoF alone or of its

    marginal increase in value when combined with

    non-GoF work, including surveillance.

    In other words, should conversation be about

    marginal possible benefits vs marginal increase

    in risks?

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    5/9

    Range of Options

    Policy options being discussed basically are in two

    camps: prohibiting (but which?) or regulating (but

    how? how tightly or lightly?).

    Must keep in mind that much will be determined by

    presumptions

    Given that many things will inevitably fall in a grey

    zone, the default will determine whether they go

    forward or remain stopped.

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    6/9

    Effect on Pipeline

    Given the key role of the grey zone, it is not

    surprising there is so much attention being given

    to describing what should clearly be allowed.

    Concern that uncertainty or restriction will deter

    young scientists from entering the field (c.f. hESC

    research)

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    7/9

    Approaches

    One possibility is to create a threshold beyond

    which experiments are given special attention.

    Another is pure case by case with each factor

    reviewed independently and then holistically

    Third is risk-based regulation that reflects

    experience with substance or setting

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    8/9

    Where is the work done?

    Many regulatory options reflect a point-

    source approach

    But if this work decentralizes, non-point

    source approaches are needed

  • 7/26/2019 Session 9: Rapporteur Summary on Policy Implications

    9/9

    Major ChallengeGlobal Nature of Work

    National culturesto what extent is there a communal agreement about the

    general balance between risk avoidance and innovation/research support?

    Governmental powerswhich powers are traditionally used to regulate or prohibit

    research? Is it done by conditions on receipt of funds, direct regulation of

    personal activity, licensing of institutions etc. Is it done primarily through ruleswith force of law or by advice and voluntary actions?

    Relative resourcesgiven that protective measures can be resource intensive

    (both equipment and personnel), and countries vary in their capacity, how much

    should be spent in order to achieve a minimum level of safety? Optimal level of

    safety?

    Inter-national governancehow should regulation or prohibition be managed in

    cases of collaborations that cross borders?